FI771684A - - Google Patents

Info

Publication number
FI771684A
FI771684A FI771684A FI771684A FI771684A FI 771684 A FI771684 A FI 771684A FI 771684 A FI771684 A FI 771684A FI 771684 A FI771684 A FI 771684A FI 771684 A FI771684 A FI 771684A
Authority
FI
Finland
Application number
FI771684A
Other languages
Finnish (fi)
Other versions
FI57597B (fi
FI57597C (fi
Inventor
Johannes Van Der Vies
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/691,103 external-priority patent/US4098802A/en
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI771684A publication Critical patent/FI771684A/fi
Publication of FI57597B publication Critical patent/FI57597B/fi
Application granted granted Critical
Publication of FI57597C publication Critical patent/FI57597C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI771684A 1976-05-28 1977-05-26 Foerfarande foer framstaellning av nya 17beta-estrar av testosteron FI57597C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69110376 1976-05-28
US05/691,103 US4098802A (en) 1975-02-18 1976-05-28 Oral pharmaceutical preparation having androgenic activity

Publications (3)

Publication Number Publication Date
FI771684A true FI771684A (fr) 1977-11-29
FI57597B FI57597B (fi) 1980-05-30
FI57597C FI57597C (fi) 1980-09-10

Family

ID=24775172

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771684A FI57597C (fi) 1976-05-28 1977-05-26 Foerfarande foer framstaellning av nya 17beta-estrar av testosteron

Country Status (12)

Country Link
JP (1) JPS52148060A (fr)
AR (1) AR214323A1 (fr)
BE (1) BE855163A (fr)
CH (1) CH627761A5 (fr)
DE (1) DE2723876C2 (fr)
DK (1) DK146096C (fr)
ES (1) ES459230A1 (fr)
FI (1) FI57597C (fr)
FR (1) FR2352832A1 (fr)
GB (1) GB1567515A (fr)
NL (1) NL7705790A (fr)
SE (1) SE425493B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004506698A (ja) * 2000-08-23 2004-03-04 アクゾ・ノベル・エヌ・ベー ヒトに用いるためのテストステロンエステル製剤
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
GB0807605D0 (en) 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TW201521731A (zh) * 2013-03-15 2015-06-16 利波辛股份有限公司 用於口服之脂平衡的長鏈睪固酮酯
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
DK236877A (da) 1977-11-29
DK146096C (da) 1983-11-21
DE2723876A1 (de) 1977-12-15
AR214323A1 (es) 1979-05-31
SE7706235L (sv) 1977-11-29
JPS52148060A (en) 1977-12-08
FR2352832B1 (fr) 1980-07-11
FI57597B (fi) 1980-05-30
BE855163A (fr) 1977-11-28
CH627761A5 (en) 1982-01-29
JPS6145637B2 (fr) 1986-10-08
DE2723876C2 (de) 1986-10-30
GB1567515A (en) 1980-05-14
FR2352832A1 (fr) 1977-12-23
FI57597C (fi) 1980-09-10
DK146096B (da) 1983-06-27
ES459230A1 (es) 1978-11-16
NL7705790A (nl) 1977-11-30
SE425493B (sv) 1982-10-04

Similar Documents

Publication Publication Date Title
FR2357042B1 (fr)
FR2364394B1 (fr)
CH637799GA3 (fr)
FI771684A (fr)
CS177447B1 (fr)
CS178347B1 (fr)
CS188447B1 (fr)
CH603218A5 (fr)
CH606853A5 (fr)
CH594305A5 (fr)
CH596605A5 (fr)
CH596975A5 (fr)
CH598535A5 (fr)
CH599114A5 (fr)
CH599809A5 (fr)
CH599834A5 (fr)
CH600508A5 (fr)
CH601629A5 (fr)
CH601664A5 (fr)
CH601921A5 (fr)
CH602143A5 (fr)
CH602451A5 (fr)
CH602473A5 (fr)
CH603121A5 (fr)
CH586949A5 (fr)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: AKZO N.V.